Welcome to the AHA/ASA Newsroom

FOR IMMEDIATE RELEASE   DALLAS, February 6, 2012 – The American Heart Association/American Stroke Association has been compiling an annual list of the major advances in heart disease and stroke research since 1996. This year, the...

NOTE ALL TIMES ARE CENTRAL. ALL TIPS ARE EMBARGOED UNTIL THE TIME OF PRESENTATION OR 3 P.M. CT/4 P.M. ET EACH DAY, WHICHEVER COMES FIRST. For more information Feb. 1-3, call Karen Astle, Bridgette McNeill, Julie Del Barto or Carrie Thacker at the...

Study Highlights: Combining the anti-blood clot medicine clopidogrel (Plavix) with aspirin is unlikely to prevent recurrent small subcortical strokes, which are caused by blood clots deep in the middle of the brain. The combination treatment...

Study Highlights: A new drug, AX200, which produced improvement in an earlier small clinical trial, didn’t improve disability among stroke patients when begun within nine hours of the onset of stroke symptoms. Ninety days after treatment,...

Study Highlights: Rare genetic mutations may help explain why members of certain families have a high risk of aneurysm. A new screening technique may help find relevant genes and screen people for risk. NEW ORLEANS, Feb. 3, 2012 — An...

Study Highlights: In the largest and longest head-to-head comparison of two anti-clotting medications, warfarin was similar to aspirin in preventing deaths and strokes in patients with heart failure with normal heart rhythm. Although there was no...

Study Highlights: In a small study comparing two devices, an experimental mechanical blood clot remover called the SOLITAIRE; Flow Restoration Device outperformed an FDA-approved mechanical clot remover, known as the MERCI; retriever. More patients...